ArticleNeurogenetics2025
LAMB1-associated leukoencephalopathy: a continuum from a prenatal, recessive syndrome to a dominant, adult-onset disorder.
Article in Neurogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LAMB1-related adult-onset leukoencephalopathy presenting with cognitive decline: diagnostic workup and review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 1 year 11 months-old female patient displayed focal seizures symptoms with good response to oxcarbazepine. Her brain magnetic resonance imaging (MRI) showed white-matter, bilateral and symmetrical hyperintense foci in periventricular parietal and frontal regions with U-fiber sparing. A gene panel requested for the study of leukodystrophies and subsequent segregation reported compound heterozygous variants in LAMB1 gene: c.3659_3660delTG (p.Val1220Glyfs*31), maternally inherited, and c.2942 A > T (p.Asn981Ile), paternally inherited. Published cases with biallelic, loss-of-function LAMB1 variants displayed a broad phenotype that depends on the deleteriousness of the variants, ranging from mildly affected individuals to severely affected ones with multiple other anomalies. Also, monoallelic, presumably toxic gain-of-function LAMB1 variants can also cause leukoencephalopathy but whose onset of manifestations is in adulthood. The cases affected by the dominant condition also exhibit a broad range of manifestations and brain imaging anomalies, some of them overlap to those seen in the recessive LAMB1-related leukoencephalopathy. This work unveils the relevance of performing a comprehensive literature review for a better comprehension of overlapping conditions caused by variants in the same gene.
Indexed as
Identifiers
41364132What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.